Bayer explores possible sale of diabetes device unit: Bloomberg

(Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

from Reuters: Deals http://ift.tt/1tqtQJd